Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2025-12-24 @ 9:56 PM
NCT ID:
NCT05732532
Eligibility Criteria:
Inclusion Criteria:
* Treated for headache including but not limited to occipital neuralgia, episodic migraine, chronic migraine and/or cervicogenic headache.
* Stable on preventative medication dosing for at least 1 month prior to occipital nerve block and no change in preventative medication regimen during the course of the study.
* Able to understand the requirements of the study and return for treatment.
* Able to independently provide informed consent.
Exclusion Criteria:
* Diagnosis of cluster headache according to the International Classification of Headache Disorders 3rd edition.
* Occipital or other cranial nerve block administered within 3 months prior to initiation of study.
* History of adverse reaction or contraindication to any of the study ingredients (bupivacaine, lidocaine, dexamethasone).
* Pregnancy.
* Infection or bleeding at site of injection.
* Cranial bone or cervical spine defects/prior surgeries near injection site that prohibit use of landmark-based technique.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05732532
Study Brief:
Protocol Section:
NCT05732532